The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases

Inflammation is a crucial pathological feature in cancers and kidney diseases, playing a significant role in disease progression. Cyclin-dependent kinases CDK4 and CDK6 not only contribute to cell cycle progression but also participate in cell metabolism, immunogenicity and anti-tumor immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xuan-Bing, Dai, Zhi-Cheng, Zou, Rong, Tang, Ji-Xin, Yao, Cui-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487876/
https://www.ncbi.nlm.nih.gov/pubmed/37686364
http://dx.doi.org/10.3390/ijms241713558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487876/
https://www.ncbi.nlm.nih.gov/pubmed/37686364
http://dx.doi.org/10.3390/ijms241713558

Ejemplares similares